|
Volumn 16, Issue 2-3, 1996, Pages 43-49
|
Imipenem-resistant Ps. aeruginosa bacteraemia in cancer patients: Risk factors, clinical features and outcome
b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b a,b
b
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIKACIN;
CEPHALOSPORIN DERIVATIVE;
IMIPENEM;
QUINOLONE DERIVATIVE;
THIENAMYCIN DERIVATIVE;
ADULT;
ANTIBIOTIC RESISTANCE;
ARTICLE;
BACTEREMIA;
CANCER PATIENT;
CLINICAL FEATURE;
DEATH;
GRAM NEGATIVE INFECTION;
HUMAN;
INCIDENCE;
LEUKEMIA;
MAJOR CLINICAL STUDY;
NEUTROPENIA;
PSEUDOMONAS AERUGINOSA;
RISK FACTOR;
SEPTIC SHOCK;
TREATMENT OUTCOME;
CANCER CENTER;
COMPARATIVE STUDY;
MORTALITY;
NEOPLASM;
SLOVAKIA;
ADULT;
BACTEREMIA;
CANCER CARE FACILITIES;
DRUG RESISTANCE, MICROBIAL;
HUMANS;
IMIPENEM;
INCIDENCE;
NEOPLASMS;
PSEUDOMONAS INFECTIONS;
RISK FACTORS;
SHOCK, SEPTIC;
SLOVAKIA;
THIENAMYCINS;
|
EID: 0030342575
PISSN: 02511649
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (8)
|